Search

Search Results
Results 931 - 940 of 1110 for Diabetes Type II
  • News - 25 Oct 2004
    In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative...
  • News - 19 Oct 2004
    The health benefits of exercise – across the lifespan – have been well documented. More recently, scientists have begun to demonstrate that exercise also may improve cognitive functioning in older...
  • News - 11 May 2004
    Until recently, the story on platelets was pretty simple: tiny blood cells, with limited sophistication because they had no nucleus, and their claim to fame was to be a first-responder to a wound...
  • News - 11 May 2004
    Two researchers have announced receipt of a patent on the use of MSH analogs--chemicals that regulate fat storage and metabolism in the body.
  • News - 28 Apr 2004
    AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border...
  • Drug - 7 Jul 2025
    Consumer Medicine Information (CMI) about Sacubitril/Valsartan Alphapharm intended for persons living in Australia.
  • Drug - 20 Jun 2025
    Consumer Medicine Information (CMI) about Cozavan intended for persons living in Australia.
  • Drug - 13 Jun 2025
    Consumer Medicine Information (CMI) about Omtralo intended for persons living in Australia.
  • Drug - 18 Mar 2025
    Consumer Medicine Information (CMI) about Mersynofen intended for persons living in Australia.
  • Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Tryzan intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.